AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
ETF Channel: Vanguard Russell 2000 ETF Implied Analyst Target Price of $107.79
ByAinvest
Thursday, May 22, 2025 8:08 am ET1min read
The Vanguard Russell 2000 ETF (VTWO) has an implied analyst target price of $107.79 per unit, based on the average analyst 12-month forward target price of its underlying holdings. With a recent trading price of $82.12, analysts see 31.26% upside for this ETF. Three of VTWO's underlying holdings with notable upside to their analyst target prices are scPharmaceuticals Inc (SCPH), Day One Biopharmaceuticals Inc (DAWN), and Intellia Therapeutics Inc (NTLA).
The Vanguard Russell 2000 ETF (VTWO) has garnered attention from analysts, with an implied target price of $107.79 per unit, representing a 31.26% upside from its recent trading price of $82.12 [1]. This optimism is driven by the strong performance of several of the ETF's underlying holdings.Underlying Holdings with Notable Upside
Among VTWO's underlying holdings, scPharmaceuticals Inc (SCPH), Day One Biopharmaceuticals Inc (DAWN), and Intellia Therapeutics Inc (NTLA) stand out for their significant upside potential. SCPH, for instance, has an average analyst target price of $18.63, a 30.41% increase from its recent trading price of $14.28 [1]. Similarly, DAWN has an average analyst target price of $15.50, a 28.53% increase from its recent trading price of $12.09 [1]. Intellia Therapeutics Inc (NTLA) also shows promise, with an average analyst target price of $28.33, a 40.24% increase from its recent trading price of $20.16 [1].
Analyst Justification
Analysts' optimism about these stocks is likely based on various factors, including positive clinical trial results, strong financial performance, and market trends. However, it is essential for investors to conduct their own research to determine if these targets are justified or if they reflect a more conservative or aggressive outlook.
Conclusion
The Vanguard Russell 2000 ETF (VTWO) presents an attractive opportunity for investors looking to capitalize on the potential upside in small-cap value stocks. While analysts' targets indicate significant upside potential, investors should remain cautious and conduct thorough research before making investment decisions.
References
[1] https://finance.yahoo.com/quote/VTWV/
[2] https://www.nasdaq.com/articles/implied-vonv-analyst-target-price-92-0
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet